Founded
8 Jan 1991
Address
Vulcan Capital
505 Fifth Avenue South
Suite 900
Bellevue, WA 98104
United States
Phone
Website
VCID: 30128
Profile
Founders
Corporate information
Official name
Vulcan Inc
Also known as
Vulcan Capital
Registration country
Investment activity status
Active investor
Investments
Selected investments
| Company | Country | Date | Notes | ||
|---|---|---|---|---|---|
|
ScaleFactor Inc |
United States | 8 Aug 2019 | Series C Round participant. Active |
|
|
Context Relevant Inc Provider of data science tools for financial services, helping financial institutions recommend products to clients and also detect security threats. |
United States | 16 Jul 2013 20 May 2014 22 Aug 2017 |
Series C Active |
|
|
Turi |
United States | 8 Jan 2015 | Series B Active |
|
|
Magic Leap Inc Developer of proprietary spatial computing and experiential platforms. |
United States | 21 Oct 2014 | Series B Initial investment. Round participant. Active |
|
|
4info Inc Mobile advertising network company. |
United States | 4 Aug 2013 27 Oct 2011 |
Series E Led the investment round. Active |
|
|
Siluria Technologies Inc Maker of nanotechnology-enabled products for cleantech-related markets |
United States | 1 Jul 2012 | Series C Active |
|
|
Sand 9 Inc Develops timing oscillator and frequency control products using high performance MEMS resonator technology. |
United States | 1 Jun 2012 | Series C |
|
|
|
Avalanche Technology Inc Developer of non-volatile magnetic memory technology for the memory industry |
United States | 1 Jan 2012 | Series C Active |
|
|
|
Redfin Corp Operates as an online real estate brokerage company in the United States |
United States | 1 Jul 2007 1 Nov 2009 1 Oct 2011 |
Series E Active |
|
|
|
SiOnyx Inc Photonics development firm |
United States | 20 Oct 2010 | Series B Active |
|
|
Bizo Inc A business audience marketing company. |
United States | 1 Nov 2009 | Venture Initial investment. Round participant. Active |
|
|
|
Audience Inc |
United States | 1 Feb 2009 | Series E Active |
|
|
|
BiPar Sciences Inc Biopharmaceutical company developing and commercializing tumor-selective drugs for cancer patients. |
United States | 1 Feb 2007 1 Jan 2009 |
Series C Active |
|
|
|
Infinia Corp |
United States | 22 Apr 2008 | Series B Active |